The Effects of the Combination of Walking Exercise, Muscle Electrical Stimulation (EMS), and Astaxanthin Intake on the Improvement of Muscle Function

The Effects of the Combination of Walking Exercise for 10 Minutes, Three Times per Week for 4 Weeks, Muscle Electrical Stimulation, and Astaxanthin Intake on the Improvement of Muscle Function: A Pilot Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0011696

Enrollment

Registered

2026-03-09

Start date

2023-12-04

Completion date

Unknown

Last updated

2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement, Others(Electrical muscle stimulation) : All participants will perform the same walking exercise program as the common intervention and will be allocated to either the astaxanthin s

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Participants will be included if they meet all of the following criteria: adults aged 18 years or older; individuals without musculoskeletal or neurological disorders affecting movement; individuals able to walk independently without assistive devices or assistance; individuals capable of performing activities of daily living independently; and individuals who spend most of their daily life in a sedentary lifestyle.

Exclusion criteria

Exclusion criteria: Participants will be excluded if they meet any of the following criteria: individuals with implanted cardiac devices such as pacemakers, defibrillators, or other electronic recording devices; individuals with artificial implants or metallic materials in soft tissues; individuals with a history of cardiovascular diseases, including heart failure, angina, arrhythmia, aortic stenosis, myocardial infarction, or atherosclerotic disease; individuals with musculoskeletal or neurological disorders affecting movement; individuals with a history of severe psychiatric disorders as determined by the investigator; individuals with clinically significant abnormal findings on physical examination as determined by the investigator; individuals with central nervous system or neurological disorders, including multiple sclerosis, epilepsy, or a history of seizures; individuals with gastrointestinal or liver diseases, including liver cirrhosis or viral hepatitis; individuals with a history of alcohol dependence or substance abuse; individuals who are currently participating or have participated within the past 30 days in another clinical trial involving investigational products, unapproved drugs, or medical devices; and individuals with a history of kidney, liver, or pulmonary diseases, including chronic asthma.

Design outcomes

Primary

Measure	Time frame
Isokinetic muscle function	—

Secondary

Measure	Time frame
Body composition;Grip Strength	—

Countries

Korea, Republic of

Contacts

Public ContactSeon-Ho Eom

Soon Chun Hyang University

ush1995@sch.ac.kr+82-41-530-1293

Outcome results